Correlation Between Salesforce and Pharmaceuticals Ultrasector
Can any of the company-specific risk be diversified away by investing in both Salesforce and Pharmaceuticals Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Pharmaceuticals Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Pharmaceuticals Ultrasector Profund, you can compare the effects of market volatilities on Salesforce and Pharmaceuticals Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Pharmaceuticals Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Pharmaceuticals Ultrasector.
Diversification Opportunities for Salesforce and Pharmaceuticals Ultrasector
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Salesforce and Pharmaceuticals is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Pharmaceuticals Ultrasector Pr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmaceuticals Ultrasector and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Pharmaceuticals Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmaceuticals Ultrasector has no effect on the direction of Salesforce i.e., Salesforce and Pharmaceuticals Ultrasector go up and down completely randomly.
Pair Corralation between Salesforce and Pharmaceuticals Ultrasector
Considering the 90-day investment horizon Salesforce is expected to under-perform the Pharmaceuticals Ultrasector. But the stock apears to be less risky and, when comparing its historical volatility, Salesforce is 1.01 times less risky than Pharmaceuticals Ultrasector. The stock trades about -0.13 of its potential returns per unit of risk. The Pharmaceuticals Ultrasector Profund is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 2,129 in Pharmaceuticals Ultrasector Profund on May 22, 2025 and sell it today you would earn a total of 513.00 from holding Pharmaceuticals Ultrasector Profund or generate 24.1% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Salesforce vs. Pharmaceuticals Ultrasector Pr
Performance |
| Timeline |
| Salesforce |
| Pharmaceuticals Ultrasector |
Salesforce and Pharmaceuticals Ultrasector Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and Pharmaceuticals Ultrasector
The main advantage of trading using opposite Salesforce and Pharmaceuticals Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Pharmaceuticals Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmaceuticals Ultrasector will offset losses from the drop in Pharmaceuticals Ultrasector's long position.| Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify Class A | Salesforce vs. Workday |
| Pharmaceuticals Ultrasector vs. Fbanjx | Pharmaceuticals Ultrasector vs. Fdzbpx | Pharmaceuticals Ultrasector vs. Ab Value Fund | Pharmaceuticals Ultrasector vs. Balanced Fund Retail |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |